Les marqueurs biologiques protéiques du liquide cé phalorachidien: Caractéristiques et implications cliniques dans les démences

7Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Given the current developments of therapeutic strategies in the field of neurodegenerative disorders, exact diagnosis, especially at an early stage, is becoming increasingly crucial for optimal patient care. Importantly, the new diagnosis criteria of dementia include functional imagery as well as CSF biomarkers. Proteomics investigations of these CSF biomarkers have produced quite promising results. The interest of CSF analysis resides in the anatomical and pathophysiological characteristics of this fluid. In this article, we will review current proteomics investigations of CSF which have led to the discovery and validation of biomarkers, mainly in the field of neurodegenerative disorders in Alzheimers disease. pathophysiological characteristics of this fluid. In this article, we will review current proteomics investigations of CSF which have led to the discovery and validation of biomarkers, mainly in the field of neurodegenerative disorders in Alzheimers disease. © 2008 Elsevier Masson SAS.

Cite

CITATION STYLE

APA

Gabelle, A., Roche, S., & Lehmann, S. (2009, March). Les marqueurs biologiques protéiques du liquide cé phalorachidien: Caractéristiques et implications cliniques dans les démences. Revue Neurologique. https://doi.org/10.1016/j.neurol.2008.05.004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free